The centre will address the unmet clinical need for patients with B cell malignancies.
We aim to expand the biological understanding of B-cell malignancies and translate advances into improved patient treatment.
We also aim to improve treatment choices, provide drug sensitivity diagnostics, identify new therapeutic targets, and implement novel treatments in clinical trials.
We will inform users of current knowledge and available treatment options.
The Centre is headed by Professor Ludvig Munthe and comprises two nodes at the Oslo University Hospital (OUH). We are situated at OUH-Rikshospitalet and OUH-Radiumhospitalet and are part of the Medical Faculty’s Institute of Clinical Medicine.